Tags: fda | approves | hepc | drug

FDA Approves Breakthrough Hepatitis C Drug

Friday, 06 Dec 2013 05:40 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a treatment for chronic infection with the liver-destroying hepatitis C virus.

The pill is the first approved to treat certain types of hepatitis C infection without the need for interferon, an injected drug that can cause severe flu-like symptoms.

Hepatitis C, which is often undiagnosed, affects about 3.2 million Americans, killing more than 15,000 each year, mostly from illnesses such as cirrhosis and liver cancer.

Gilead said Sovaldi can be used in combination with ribavirin, an older antiviral pill, for patients with genotypes 2 and 3 infections, which account for about 28 percent of U.S. patients infected with the virus.

For patients with genotypes 1 or 4, the new drug needs to be used with both interferon and ribavirin, although it can be considered for use in patients with genotype 1 infections who cannot use interferon.

Gilead has estimated that around 70 percent of U.S. patients have genotype 1 hepatitis C infections.

The drug's approval was supported by several studies showing that it helped to eradicate the virus in significantly more patients, with fewer side effects, than the current drug regimen.

Sovaldi is the first in a new class of medications known as nucleotide analogue inhibitors, or "nukes," designed to block a specific protein that the hepatitis C virus needs to copy itself.

Analysts, on average, have forecast Sovaldi sales of $1.9 billion next year, according to BMO Capital Markets.

Shares of Gilead, which have nearly doubled over the past 12 months, were little changed in after-hours trading. The shares rose 1 percent to close at $73.99 in regular Nasdaq trading on Friday.

 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Sheriffs in Southwest: The Border Is 'Spiraling Out of Control'

Wednesday, 17 Sep 2014 22:04 PM

Describing the immigration crisis as "spiraling out of control," a coalition of five sheriffs' organizations in the Sout . . .

Alan Colmes, Dennis Kucinich: Would Not Have Bombed ISIS

Wednesday, 17 Sep 2014 21:10 PM

Liberal pundit Alan Colmes and former Democratic Rep. Dennis Kucinich caught the ire of Fox News Channel host Bill O'Rei . . .

Poll: Most Americans Want Strong US Global Leadership

Wednesday, 17 Sep 2014 20:47 PM

Most Americans want the United States to be an active player on the global stage, even after more than a decade of wars  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved